The dedicated market facing global event for the synbio sector

Building on the successful launch event in 2019, SynBio Markets 2020 will once again connect synthetic biology investors, academics and innovators to commercial end market customers across a variety of sectors. Focusing on investment and the commercial models essential to success, learn from industry leaders detailing what their technology has delivered and how they developed it, along with a unique insight into the challenges they have overcome and future opportunities they are focused on.

Download 2020 Prospectus

Key themes for 2020

COMMERCIAL
This year’s event has a renewed focus on end-user applications, with a number of brands speaking and attending to learn and showcase how synthetic biology can create and support, new and better products.
SUSTAINABLE
But beyond profit, in year beset with challenges we are going to highlight how synbio can help mitigate some of the effects of climate change, and bring smarter medical support and testing to the public more quickly.

Showcasing the most innovative synthetic biology start-ups

Bio Stars

Find Out More

 

The 2019 speakers included...

 

The 2019 sponsors included...

 

Co-locating with the 15th annual World Bio Markets in 2020

Now in it’s 15th year, World Bio Markets is the must attend event for the bio economy value chain. Connecting global brands and retailers to the chemical and material manufactures who can help them achieve ambitious sustainability goals, to the scale up and process engineering companies providing greater efficiencies, to the most suitable feed-stock and biomass options available, and finally, the start-ups, academia and investors driving the industry forward.

Find Out More

  • At Intrexon, we see synthetic biology as being the greatest industrial vector in all of time. The applications and potential are wide ranging and we are looking forward to sharing some of our innovations at SynBio Markets
    Randal “RJ” Kirk
  • Synthetic biology is one of our focus areas of research. The market is growing rapidly and increasing venture capital investments are directed at start-up companies in the space, some of which are our partners. We are pleased to see this event being arranged
    Jari Rautio
  • We are energized by the advances within synbio both in protein design and strain engineering. We believe that it has the potential to disrupt the status quo and address the pressing global challenges of feeding 9 billion people by 2050, improving health, and addressing the environmental challenges.
    Leigh Fritz
  • Tecan is particularly excited about the growing impact of synbio in drug discovery. We provide solutions to automate a wide range of processes used in synbio and are very keen on exchanging with the community to better support the overall research/manufacturing efforts through automation.
    Luca Valeggia
  • I am looking forward to this conference. We have always had a big conference in this space in the US, but not in Europe. I have been looking for a similar type of event to happen in Europe.
    Thomas Grotkjær
  • Synthetic biology in Europe is extremely exciting. A lot of start-ups are developing interesting solutions. So, a conference in Europe is highly impactful, allowing the industry to exchange information, meet partners and investors, and help build the European synbio community.
    Josko Bobanovic